Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04854252Completed
Randomised, open-label trial of fentanyl and dexmedetomidine in class III obesity (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Interleukin-6, Interleukin-1 beta and 1 more. Started Nov 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04854252.